HER2-low and ultralow breast cancer: interobserver challenges and lessons from a consensus study. - Koh J; Cha YJ; Cho EY; Lee A; Koo JS; Park SY; Kim MH; Jeong JH; Gong G (Journal of pathology and translational medicine, 2026)